RNAC logo

Cartesian Therapeutics (RNAC) Long Term Liabilities

Annual Total Long Term Liabilities

$677.02 M
+$630.04 M+1341.06%

31 December 2023

RNAC Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Liabilities

$433.16 M
+$10.08 M+2.38%

01 September 2024

RNAC Quarterly Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RNAC Long Term Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+1341.1%+1581.1%
3 y3 years+939.8%+565.3%
5 y5 years+1104.0%+670.4%

RNAC Long Term Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+1341.1%-36.0%+1581.1%
5 y5 yearsat high+4488.1%-36.0%+2791.4%
alltimeall timeat high+4488.1%-36.0%+3325.3%

Cartesian Therapeutics Long Term Liabilities History

DateAnnualQuarterly
Sept 2024
-
$433.16 M(+2.4%)
June 2024
-
$423.08 M(+4.4%)
Mar 2024
-
$405.35 M(-40.1%)
Dec 2023
$677.02 M(+1341.1%)
$677.02 M(+2527.6%)
Sept 2023
-
$25.77 M(-42.3%)
June 2023
-
$44.69 M(-18.1%)
Mar 2023
-
$54.58 M(+16.2%)
Dec 2022
$46.98 M(-27.8%)
-
Dec 2022
-
$46.98 M(-32.5%)
Sept 2022
-
$69.63 M(+7.6%)
June 2022
-
$64.70 M(+27.6%)
Mar 2022
-
$50.69 M(-22.2%)
Dec 2021
$65.11 M(-36.1%)
$65.11 M(-27.9%)
Sept 2021
-
$90.28 M(-7.4%)
June 2021
-
$97.45 M(-12.8%)
Mar 2021
-
$111.71 M(+9.6%)
Dec 2020
$101.89 M
$101.89 M(-8.5%)
Sept 2020
-
$111.37 M(+69.4%)
June 2020
-
$65.75 M(-2.6%)
DateAnnualQuarterly
Mar 2020
-
$67.49 M(+20.0%)
Dec 2019
$56.23 M(+281.1%)
$56.23 M(+275.3%)
Sept 2019
-
$14.98 M(-0.0%)
June 2019
-
$14.98 M(+2.5%)
Mar 2019
-
$14.62 M(-0.9%)
Dec 2018
$14.76 M(-61.5%)
$14.76 M(-6.0%)
Sept 2018
-
$15.69 M(-55.5%)
June 2018
-
$35.28 M(-3.5%)
Mar 2018
-
$36.55 M(-4.6%)
Dec 2017
$38.31 M(+85.6%)
$38.31 M(+15.0%)
Sept 2017
-
$33.33 M(+77.4%)
June 2017
-
$18.79 M(-3.5%)
Mar 2017
-
$19.46 M(-5.7%)
Dec 2016
$20.64 M(-86.4%)
$20.64 M(+63.2%)
Sept 2016
-
$12.65 M(-7.0%)
June 2016
-
$13.60 M(-3.3%)
Mar 2016
-
$14.06 M(-90.7%)
Dec 2015
$152.03 M(+50.9%)
$152.03 M
Dec 2014
$100.75 M
-

FAQ

  • What is Cartesian Therapeutics annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Cartesian Therapeutics?
  • What is Cartesian Therapeutics annual total long term liabilities year-on-year change?
  • What is Cartesian Therapeutics quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Cartesian Therapeutics?
  • What is Cartesian Therapeutics quarterly long term liabilities year-on-year change?

What is Cartesian Therapeutics annual total long term liabilities?

The current annual total long term liabilities of RNAC is $677.02 M

What is the all time high annual total long term liabilities for Cartesian Therapeutics?

Cartesian Therapeutics all-time high annual total long term liabilities is $677.02 M

What is Cartesian Therapeutics annual total long term liabilities year-on-year change?

Over the past year, RNAC annual total long term liabilities has changed by +$630.04 M (+1341.06%)

What is Cartesian Therapeutics quarterly total long term liabilities?

The current quarterly long term liabilities of RNAC is $433.16 M

What is the all time high quarterly long term liabilities for Cartesian Therapeutics?

Cartesian Therapeutics all-time high quarterly total long term liabilities is $677.02 M

What is Cartesian Therapeutics quarterly long term liabilities year-on-year change?

Over the past year, RNAC quarterly total long term liabilities has changed by +$407.39 M (+1581.13%)